Krüger N, Kong Y, Bachinger M, Kesselheim AS - New England Journal of Medicine
Patient-targeted promotion of prescription drugs has expanded beyond traditional advertising to the Internet, with celebrities and influencers increasingly endorsing products such as GLP-1s, often evading regulatory scrutiny when promotion comes from social-media figures or telehealth companies rather than manufacturers directly. Stronger guardrails are needed, including updated FDA and FTC guidance on drug risk disclosure in advertising and expanded oversight of drug-class promotion.
VIEW SOURCE
Daval CJR, Kesselheim AS - STAT
Mulsant SS, Kesselheim AS, Naci H - Journal of Cancer Policy
Avorn J - MedPage Today